Non-Interventional Registry Study to Evaluate the Effectiveness of TheraSphere® in the Treatment of Hepatocellular Carcinoma (HCC)
Clinical trial NCT04069468 · COMPLETED
Trial details
- NCT number
- NCT04069468
- Sponsor
- Boston Scientific Corporation
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2019-03-13
- Primary completion
- 2024-12-31
- Enrollment
- 1247
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.